JP2003525872A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003525872A5 JP2003525872A5 JP2001544731A JP2001544731A JP2003525872A5 JP 2003525872 A5 JP2003525872 A5 JP 2003525872A5 JP 2001544731 A JP2001544731 A JP 2001544731A JP 2001544731 A JP2001544731 A JP 2001544731A JP 2003525872 A5 JP2003525872 A5 JP 2003525872A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- mammal
- pharmaceutically acceptable
- pharmaceutical composition
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 C*1CCCC1 Chemical compound C*1CCCC1 0.000 description 2
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/464,511 US6262096B1 (en) | 1997-11-12 | 1999-12-15 | Aminothiazole inhibitors of cyclin dependent kinases |
| US09/464,511 | 1999-12-15 | ||
| US09/616,629 | 2000-07-26 | ||
| US09/616,629 US6214852B1 (en) | 1998-10-21 | 2000-07-26 | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| PCT/US2000/033113 WO2001044241A1 (en) | 1999-12-15 | 2000-12-07 | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003525872A JP2003525872A (ja) | 2003-09-02 |
| JP2003525872A5 true JP2003525872A5 (cg-RX-API-DMAC7.html) | 2008-01-31 |
Family
ID=27041009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001544731A Pending JP2003525872A (ja) | 1999-12-15 | 2000-12-07 | サイクリン依存性キナーゼのｎ−［５−［［［５−アルキル−２−オキサゾリル］メチル］チオ−２−チアゾリル］カルボキサミドインヒビター |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6214852B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1240165B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2003525872A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20020067547A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1433415A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE294800T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU774381B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2394544A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO5251464A1 (cg-RX-API-DMAC7.html) |
| CZ (1) | CZ20022013A3 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60019964T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1240165T3 (cg-RX-API-DMAC7.html) |
| EE (1) | EE200200306A (cg-RX-API-DMAC7.html) |
| ES (1) | ES2241678T3 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0300974A3 (cg-RX-API-DMAC7.html) |
| PE (1) | PE20010932A1 (cg-RX-API-DMAC7.html) |
| PL (1) | PL364884A1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1240165E (cg-RX-API-DMAC7.html) |
| SI (1) | SI20975B (cg-RX-API-DMAC7.html) |
| TW (1) | TWI265930B (cg-RX-API-DMAC7.html) |
| UY (1) | UY26480A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2001044241A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US6414156B2 (en) | 1998-10-21 | 2002-07-02 | Bristol-Myers Squibb Company | Process for preparing azacycloalkanoylaminothiazoles |
| US6515004B1 (en) | 1999-12-15 | 2003-02-04 | Bristol-Myers Squibb Company | N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| US6392053B2 (en) * | 1999-12-15 | 2002-05-21 | Bristol-Myers Squibb Company | Process for preparing arylacetylaminothiazoles |
| US6534531B2 (en) * | 2000-04-27 | 2003-03-18 | Bristol-Myers Squibb Company | Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy |
| EP1724270A3 (en) * | 2001-07-19 | 2007-01-03 | Pfizer Italia S.r.l. | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| PL367938A1 (en) | 2001-07-19 | 2005-03-07 | Pharmacia Italia S.P.A. | Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| ES2183734B1 (es) * | 2001-08-02 | 2004-06-16 | Consejo Sup. Investigaciones Cientificas | Derivados de 4-4'-bipiridil-2-2'-bisoxazoles y 4-4'-bipiridil-2-2'-bistiazoles como agentes antineoplasicos. |
| KR20040029393A (ko) * | 2001-08-03 | 2004-04-06 | 노보 노르디스크 에이/에스 | 신규한 2,4-디아미노티아졸 유도체 |
| CA2455753A1 (en) * | 2001-08-03 | 2003-02-13 | Novo Nordisk A/S | Novel 2,4-diaminothiazole derivatives |
| TW200401638A (en) * | 2002-06-20 | 2004-02-01 | Bristol Myers Squibb Co | Heterocyclic inhibitors of kinases |
| DE10300124A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Ag | Verfahren zur Herstellung von Arylalkinen |
| AU2004262369A1 (en) * | 2003-07-29 | 2005-02-10 | Bristol-Myers Squibb Company | Biomarkers of cyclin-dependent kinase modulation |
| US7888504B2 (en) * | 2006-07-06 | 2011-02-15 | Bristol-Myers Squibb Company | Glucokinase activators and methods of using same |
| WO2008049856A2 (en) * | 2006-10-25 | 2008-05-02 | Ingenium Pharmaceuticals Gmbh | Methods of treating pain using cdk inhibitors |
| WO2011090738A2 (en) | 2009-12-29 | 2011-07-28 | Dana-Farber Cancer Institute, Inc. | Type ii raf kinase inhibitors |
| SI2760860T1 (sl) * | 2011-09-28 | 2017-04-26 | Euro-Celtique S.A. | Derivati dušikove gorčice |
| AU2012340200B2 (en) | 2011-11-17 | 2017-10-12 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-Jun-N-Terminal Kinase (JNK) |
| AR092790A1 (es) | 2012-02-01 | 2015-05-06 | Euro Celtique Sa | Derivados bencimidazolicos del acido hidroxamico |
| WO2014063068A1 (en) | 2012-10-18 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| WO2014063061A1 (en) | 2012-10-19 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
| CA2927920A1 (en) | 2013-10-18 | 2015-04-23 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7) |
| EP3057955B1 (en) | 2013-10-18 | 2018-04-11 | Syros Pharmaceuticals, Inc. | Heteroaromatic compounds useful for the treatment of prolferative diseases |
| GB201409471D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB201409488D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB201409485D0 (en) | 2014-05-28 | 2014-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| AU2015371251B2 (en) | 2014-12-23 | 2020-06-11 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
| US10550121B2 (en) | 2015-03-27 | 2020-02-04 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| CA2986441A1 (en) | 2015-06-12 | 2016-12-15 | Dana-Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
| WO2017044858A2 (en) | 2015-09-09 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| AU2016426574B2 (en) | 2016-10-11 | 2023-07-13 | Euro-Celtique S.A. | Hodgkin lymphoma therapy |
| GB201709403D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating sarcoma |
| GB201709406D0 (en) | 2017-06-13 | 2017-07-26 | Euro-Cletique S A | Compounds for treating TNBC |
| GB201709405D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating ovarian cancer |
| GB201709402D0 (en) | 2017-06-13 | 2017-07-26 | Euro Celtique Sa | Compounds for treating t-pll |
| CA3099763A1 (en) | 2018-06-25 | 2020-01-02 | Dana-Farber Cancer Institute, Inc. | Taire family kinase inhibitors and uses thereof |
| CA3124001A1 (en) | 2018-12-18 | 2020-06-25 | Mundipharma International Corporation Limited | Compounds for treating lymphoma or a t-cell malignant disease |
| CA3124422A1 (en) | 2018-12-28 | 2020-07-02 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 and uses thereof |
| CN117049976A (zh) * | 2023-08-16 | 2023-11-14 | 四川伊诺达博医药科技有限公司 | 一种n-乙基-2-(4-甲酰基苯基)乙酰胺的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1088049A (en) | 1975-06-03 | 1980-10-21 | Takashi Masugi | 3-substituted-7-substituted alkanamido-3-cephem-4- carboxylic acid compounds and processes for preparation thereof |
| CA1201431A (en) | 1981-12-17 | 1986-03-04 | Daiei Tunemoto | .beta.-LACTAM COMPOUNDS, PROCESS FOR THE PREPARATION THEREOF AND INTERMEDIATE PRODUCTS FOR THE PREPARATION THEREOF |
| TW205041B (cg-RX-API-DMAC7.html) | 1989-08-07 | 1993-05-01 | Fujisawa Pharmaceutical Co | |
| US5491157A (en) | 1993-05-10 | 1996-02-13 | Eastman Kodak Company | Method and composition for the prevention, control and amelioration of soilborne fungi and disease caused thereby |
| IL112721A0 (en) | 1994-03-10 | 1995-05-26 | Zeneca Ltd | Azole derivatives |
| JPH10510258A (ja) | 1994-12-09 | 1998-10-06 | 藤沢薬品工業株式会社 | セフェム化合物およびその医薬用途 |
| IL117620A0 (en) | 1995-03-27 | 1996-07-23 | Fujisawa Pharmaceutical Co | Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same |
| AUPN801196A0 (en) | 1996-02-12 | 1996-03-07 | Fujisawa Pharmaceutical Co., Ltd. | New cephem compounds and pharmaceutical use thereof |
| NZ503788A (en) | 1997-10-27 | 2002-11-26 | Agouron Pharma | 4-aminothiazole derivatives and their use as inhibitors of cyclin-dependent kinases |
| US6040321A (en) | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| GB9823871D0 (en) | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
-
2000
- 2000-07-26 US US09/616,629 patent/US6214852B1/en not_active Expired - Lifetime
- 2000-12-07 CA CA002394544A patent/CA2394544A1/en not_active Abandoned
- 2000-12-07 PT PT00982481T patent/PT1240165E/pt unknown
- 2000-12-07 DK DK00982481T patent/DK1240165T3/da active
- 2000-12-07 SI SI200020060A patent/SI20975B/sl not_active IP Right Cessation
- 2000-12-07 WO PCT/US2000/033113 patent/WO2001044241A1/en not_active Ceased
- 2000-12-07 KR KR1020027007617A patent/KR20020067547A/ko not_active Ceased
- 2000-12-07 EE EEP200200306A patent/EE200200306A/xx unknown
- 2000-12-07 HU HU0300974A patent/HUP0300974A3/hu unknown
- 2000-12-07 EP EP00982481A patent/EP1240165B1/en not_active Expired - Lifetime
- 2000-12-07 DE DE60019964T patent/DE60019964T2/de not_active Expired - Lifetime
- 2000-12-07 CN CN00818899A patent/CN1433415A/zh active Pending
- 2000-12-07 ES ES00982481T patent/ES2241678T3/es not_active Expired - Lifetime
- 2000-12-07 CZ CZ20022013A patent/CZ20022013A3/cs unknown
- 2000-12-07 AU AU19506/01A patent/AU774381B2/en not_active Ceased
- 2000-12-07 JP JP2001544731A patent/JP2003525872A/ja active Pending
- 2000-12-07 PL PL00364884A patent/PL364884A1/xx not_active Application Discontinuation
- 2000-12-07 AT AT00982481T patent/ATE294800T1/de active
- 2000-12-11 TW TW089126395A patent/TWI265930B/zh not_active IP Right Cessation
- 2000-12-14 CO CO00095239A patent/CO5251464A1/es not_active Application Discontinuation
- 2000-12-14 UY UY26480A patent/UY26480A1/es not_active Application Discontinuation
- 2000-12-15 PE PE2000001348A patent/PE20010932A1/es not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003525872A5 (cg-RX-API-DMAC7.html) | ||
| SI20975B (sl) | N-/5-///5-alkil-2-oksazolil/metil/tio/-2-tiazolil/-karboksamidni inhibitorji ciklodekstrin odvisne kinaze | |
| US9187465B2 (en) | Oxazole tyrosine kinase inhibitors | |
| JP2019077725A5 (cg-RX-API-DMAC7.html) | ||
| RU2005109561A (ru) | Новые производные аминоиндазолов в качестве лекарственных средств и содержащие их фармацевтические композиции | |
| JP2022096662A5 (cg-RX-API-DMAC7.html) | ||
| CA2478068A1 (en) | Dihydropyrazole compounds useful for treating or preventing cancer | |
| RU2386630C2 (ru) | Соединения и композиции в качестве ингибиторов протеинтирозинкиназы | |
| RU2455288C2 (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| RU2005121897A (ru) | Производные аминоиндазолов и их применение в качестве ингибиторов киназ | |
| JP2005524660A5 (cg-RX-API-DMAC7.html) | ||
| RU2017121044A (ru) | Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы | |
| JP2010533158A5 (cg-RX-API-DMAC7.html) | ||
| JP2014511869A5 (cg-RX-API-DMAC7.html) | ||
| RU2012143689A (ru) | Спироциклические соединения и их применение в качестве терапевтических агентов и диагностических зондов | |
| IL196129A (en) | Human protein tyrosine phosphatase inhibitors, compositions comprising such compounds and uses thereof in the preparation of medicaments for regulating angiogenesis | |
| US20130096149A1 (en) | Heteroaryl compounds and compositions as protein kinase inhibitors | |
| RU2003118448A (ru) | Производные замещенного триазолдиамина и их применение в качестве ингибиторов киназы | |
| CA2610888A1 (en) | Inhibitors of akt activity | |
| RU2002119016A (ru) | N-[5-[[[5-алкил-2-оксазолил]метил]тио]-2-тиазолил]карбоксамидные ингибиторы циклин-зависимых киназ | |
| JP2003511384A5 (cg-RX-API-DMAC7.html) | ||
| JP2006503081A5 (cg-RX-API-DMAC7.html) | ||
| HRP20100714T1 (hr) | Derivati 5-(benz-(z)-iliden)-tiazolidin-4-ona kao imunosupresivna sredstva | |
| JP2014523400A5 (cg-RX-API-DMAC7.html) | ||
| RU2019136279A (ru) | C5 -Анилинохиназолиновые соединения и их использование в лечении рака |